REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>

Hikma PharmaceuticalsAnnouncement

24/05/2016 07:05

RNS Number : 0945Z
Hikma Pharmaceuticals Plc
24 May 2016
Annex DTR3
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters.
1.
Name of the issuer
HIKMA PHARMACEUTICALS PLC
2.
State whether the notification relates to (i) a
transaction notified in accordance with DTR 3.1.2 R, 
(ii) a disclosure made in accordance 
LR 9.8.6R(1) or
(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).
(i) & (iii)




3.
Name of person discharging managerial
responsibilities/director
KHALID NABILSI
4.
State whether notification relates to a person
connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person
N/A




5.
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial
interest 1
3 ABOVE
6.
Description of shares (including class), debentures or derivatives or financial instruments relating to shares
ORDINARY SHARES OF 10P EACH




7.
Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
FOREST NOMINEES LIMITED
8.
State the nature of the transaction
DISPOSAL OF 20,000 SHARES. 




9.
Number of shares, debentures or financial
instruments relating to shares acquired
N/A
10.
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
N/A




11.
Number of shares, debentures or financial
instruments relating to shares disposed
20,000
12.
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
0.01%




13.
Price per share or value of transaction
22.85
14.
Date and place of transaction
23 MAY 2016, LONDON




15.
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
201,921 (0.08%)
16.
Date issuer informed of transaction
23 MAY 2016




If a person discharging managerial responsibilities has been granted options by the issuer
complete the following boxes
17.
Date of grant
N/A
18.
Period during which or date on which exercisable
N/A




19.
Total amount paid (if any) for grant of the option
N/A
20.
Description of shares or debentures involved (class and number)
N/A




21.
Exercise price (if fixed at time of grant) or
indication that price is to be fixed at the time of exercise
N/A
22.
Total number of shares or debentures over which options held following notification
N/A




23.
Any additional information
N/A
24.
Name of contact and telephone number for queries
PETER SPEIRS 0207 399 2772




Name of authorised official of issuer responsible for making notification
Peter Speirs, Company Secretary
Date of notification 24 May 2016
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1)
An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2)
An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHGUGDURBDBGLS